Minimal residual disease ctDNA testing in metastatic breast cancer patients with no radiological evidence of disease: Potentialclinical utility from real-worlddata.
Year: 2026
Type: conference-abstract
Study design: Observational Study
Source: Journal of Clinical Oncology
Authors: Caterina Gianni, Irene Azzali, Olivia Rieur, Arielle J. Medford, Nitin Katakam, Andrew A. Davis, Emily L. Podany, Alexis Ann LeVee, Letizia Pontolillo, Marla Lipsyc-Sharf, Brenno Pastò, Lorenzo Foffano, Hunter Gaudio, Eleonora Nicolo', Carolina Reduzzi, Lorenzo Gerratana, Antonino Musolino, Aditya Bardia, Massimo Cristofanilli
Institutions: Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Massachusetts General Hospital, Harvard University, Washington University in St. Louis, University of California, Los Angeles, Agostino Gemelli University Polyclinic, UCLA Health, UCLA Jonsson Comprehensive Cancer Center, Centro di Riferimento Oncologico, University of Udine, Weill Cornell Medicine, University of Milan, European Institute of Oncology
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
Funder: Ministero della Salute
OpenAlex ID: W7162679206
Cites:
Cited by:
Related to: